Article info

Download PDFPDF

160 High dose octreotide; a novel therapy for the treatment of drug refractory postural orthostatic tachycardia syndrome in patients with joint hypermobility syndrome
Free

Citation

French AE, Shepherd C, Horne A, et al
160 High dose octreotide; a novel therapy for the treatment of drug refractory postural orthostatic tachycardia syndrome in patients with joint hypermobility syndrome

Publication history

  • First published June 9, 2011.
Online issue publication 
January 18, 2021

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.